Takeda Pharmaceutical Company Limited (TAK) NYSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 9.26T |
| Enterprise Value | 13.56T |
| P/E Ratio | 41.33 |
| PEG Ratio | 0.53 |
| Price/Sales Ratio | 1.77 |
| Price/Book Ratio | 1.01 |
| Enterprise/Revenue | 2.72 |
| Enterprise/EBITDA | 9.01 |
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.04 |
| Operating Margin | 0.11 |
| Return On Assets | 0.01 |
| Return On Equity | 0.03 |
| Revenue | 4.78T |
| Revenue/Share | 2,883.52 |
| Gross Profit | 2.44T |
| EBITDA | 1.42T |
| Net Income | 203.33B |
| Diluted EPS | 63.91 |
| Total Cash | 597.63B |
| Total Cash/Share | 380.82 |
| Total Debt | 4.9T |
| Total Debt/Equity | 0.63 |
| Current Ratio | 1.27 |
| Book Value Per Share | 4,975.63 |
| 52-Week Change | 5.1 |
| 52-Week High | 18.9 |
| 52-Week Low | 12.99 |
| Moving Average 50 Days | 16.39 |
| Moving Average 200 Days | 16.01 |
| Average Volume | 3.06M |
| Shares Outstanding | 3.16B |
| % Held by Institutions | 3.11 |
| Trailing Annual Dividend Rate | 200 |
| Trailing Annual Dividend Yield | 3.97 |
| Payout Ratio | 1.63 |
| Last Split Factor | N/A |
| Last Split Date | N/A |